// AI news · 2026-10-31 · TechCrunch AI
Tyler Shultz warns AI era risks deception
Tyler Shultz, a former Theranos employee who exposed its flawed blood-testing devices, warns that the AI era presents new risks for deception due to difficulty in verifying technology authenticity.
Published 2026-10-31 00:03 (Beijing time)Source TechCrunch AIAuto-summarised, fact-checked against source
01Summary
He highlights how investors may overlook due diligence when facing unproven AI startups, especially those mimicking existing tools like ChatGPT. The Theranos case remains relevant as a cautionary tale, with Holmes reportedly continuing her venture through Haemanthus, a diagnostics firm raised $20 million.
Summarised from the original article by an open-source model, then checked automatically: every number and English name must appear in the source. The original article is authoritative.
02Key points
- Theranos devices were flawed and never functioned as claimed despite $10B valuation.
- AI makes it hard to distinguish genuine innovation from simple wrappers like ChatGPT.
- Investors face significant due diligence challenges in the current AI boom.
- Holmes continues with Haemanthus, a 'Theranos 2.0' firm raised $20M.
03Source
TechCrunch AI · published 2026-10-31 00:03 Beijing time
05Related news
- Starbucks Tests AI Personalized Drive-Thru Menu2026-10-31 · The Verge AI
- OpenAI Updates AI Behavior Guidelines Emphasizing Correctability2026-10-31 · The Decoder
- Thrive Holdings Acquires ADT with OpenAI Backing2026-10-30 · TechCrunch
- Oracle Announces Cloud and AI Investment Plan2026-10-29 · IT之家
- Alphabet Profit Slips, Shares Fall2026-10-29 · Guardian Tech
- Microsoft Reports $10B Revenue from OpenAI in Q32026-10-29 · TechCrunch AI
From AIMap AI news: collected from 1,100+ official and media sources. Summaries only restate the original article; follow the link for the full story. All AI news · Today